At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 222 enrolled
Drug / intervention
bimatoprost eye drops +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
In Brief
A Phase 2 clinical trial evaluating bimatoprost eye drops and placebo for Glaucoma and Ocular Hypertension. Completed, enrolled 222 participants across 1 site.
Detailed Summary
A one month study which will determine the safety and efficacy of bimatoprost eye drops in patients with glaucoma or ocular hypertension
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Ocular Hypertension
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 2007
Enrollment StartNov 2007
Primary CompletionMay 2008
TodayJul 2026
First PostedOct 2, 2007
Enrollment StartNov 1, 2007
Primary CompletionMay 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.8 years ago
Interventions
bimatoprost eye dropsdrug
1 drop in each eye daily for 1 month
placebodrug
1 drop in each eye daily for 1 month